The WHO said funding should be maintained for programmes like PEPFAR, which provides HIV treatment and testing to millions of people worldwide. View on euronews

The World Health Organization (WHO) expresses deep concern on the implications of the immediate funding pause for HIV programmes in low- and middle-income countries.

A move by the Trump administration to freeze funding for PEPFAR, the widely heralded international HIV/AIDS program, is putting countless lives at immediate risk, experts say.

The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future of PEPFAR, which has saved 25 million lives.

The World Health Organization on Tuesday urged the United States to reconsider its decision to suspend funding for HIV treatment programs in developing countries, after President Donald Trump ordered a freeze on foreign aid.

A recent flurry of executive orders and surprise actions by the Trump administration have roiled WHO, the CDC and the international public health community.

Experts say the sudden stoppage is a surprise and will set back work on investigating and trying to stop outbreaks of Marburg virus and mpox in Africa.

As President Donald Trump uses his executive authority to smash and slash programs that do not conform to his America First ideals, the President’s Emergency Plan for AIDS Relief (PEPFAR) was yet another foreign aid program put on the chopping block for a 90-day period.

The Trump administration's freeze on U.S. foreign aid has halted the distribution of lifesaving HIV medications.

Australian and New Zealand aid and support will be crucial in containing Fiji’s serious HIV outbreak – including combating the drug trade that is fuelling it.

The extent of the impacts of the Trump administration’s sudden 90-day freeze of almost all foreign aid is still unclear almost a week on, as officials and aid workers overseas try to make sense of which activities must be suspended.

The Trump administration's aid freeze affects HIV treatment access. Find out how organizations are coping with the directive.